highly significantp < 0.0001
While both monotherapies induced a modest increase in CD69 expression, the combination treatment led to highly significant upregulation compared with the vehicle ( p < 0.0001 for CD4+, p = 0.0005 for CD8+, Dunn’s test).
While both monotherapies induced a modest increase in CD69 expression, the combination treatment led to highly significant upregulation compared with the vehicle ( p < 0.0001 for CD4+, p = 0.0005 for CD8+, Dunn’s test).